Fingerprint
Dive into the research topics of 'The anti-C5a antibody vilobelimab efficiently inhibits C5a in patients with severe COVID-19'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
The anti-C5a antibody vilobelimab efficiently inhibits C5a in patients with severe COVID-19
A.P.J. Vlaar*, E.H.T. Lim, S. de Bruin, S. Ruckinger, K. Pilz, M.C. Brouwer, R.F. Guo, L.M.A. Heunks, M.H. Busch, P. van Paassen, N.C. Riedemann, D. van de Beek
*Corresponding author for this work
Research output: Contribution to journal › Article › Academic › peer-review